FLUIDDA
Business Services · Belgium · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Groeningenlei 132, Kontich, Flanders, 25...Phone Number
+32 34508720Website
www.fluidda.comRevenue
$15.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About FLUIDDA
Fluidda is a leader in Functional Respiratory Imaging (FRI), focusing on understanding lung pathology and physiology to optimize respiratory treatment. The company provides innovative solutions for healthcare professionals, including personalized medicine and improved diagnostic tools, aimed at enhancing patient care and reducing healthcare costs. Fluidda collaborates with pharmaceutical and biotech companies to accelerate drug development and improve the lives of patients with respiratory diseases. Their technology combines advanced imaging and artificial intelligence to deliver insights that support better treatment pathways for patients worldwide.Explore more
FLUIDDA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FLUIDDA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once FLUIDDA has new funding data
Click to see if FLUIDDA had a recent Job posting/layoffs
Product Launch: Get notified when FLUIDDA launches new products
Congratulate Masked Content for being promoted to Masked Content at FLUIDDA
Competitive Alert! Recent activity has been detected by your competitor Masked Content
FLUIDDA, which may be a good buyer, showed buying intent in Masked Content Topic
Check if FLUIDDA has recently received funding, and reach out quickly before it becomes old news!
Check out if FLUIDDA is spiking on competitors!
Earning: See what the market has to say on FLUIDDA recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
FLUIDDA is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
FLUIDDA is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about FLUIDDA.
FLUIDDA financials insights
Gather financial insights about FLUIDDA, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Other Financing Round
$2M
FLUIDDA Tech Stack
A closer look at the technologies used by FLUIDDA
FLUIDDA News & Media
Cereno Scientific signs agreement with Fluidda, to evaluate the impact of its HDAC inhibitor CS1 on reverse remodeling of pulmonary vessels in patients with PAH
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that the Company has signed an agreement with medical technology company Fluidda on Respiratory Imaging solutions, with the aim to visualize signs of reverse remodeling of lead drug candidate CS1 in Pulmonary Arterial Hypertension (PAH) in a clinical setting. “We have a vision to develop new therapies which address the root cause of carGossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH), today announced that data from its functional respiratory imaging, or FRI, sub-study of the successful Phase 2 TORREY Study of seralutinib in patients with PAH will be presented at the European Respiratory Society International Congress 2023. Dr. Roham Zamanian, ProfesFluidda’s Novel Approach to Assessing Lung Function Improves Detection, Diagnosis, Treatment in Military Burn Pit Subject
Proprietary FRI Technology Comes as Veterans’ Demand for Disability Benefits Grows Fluidda, the world leader in the field of Functional Respiratory... Read More The post Fluidda’s Novel Approach to Assessing Lung Function Improves Detection, Diagnosis, Treatment in Military Burn Pit Subject appeared first on citybiz.Aptar Expands Pharmaceutical Services; Announces Exclusive Collaboration Between Aptar Pharma and Fluidda
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Expands Pharmaceutical Services and Announces Exclusive Collaboration Between Aptar Pharma and Fluidda.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding FLUIDDA
Sign Up For FreeTo access detailed company insights
Fluidda is a leader in Functional Respiratory Imaging (FRI), focusing on understanding lung pathology and physiology to optimize respiratory treatment. The company provides innovative solutions for healthcare professionals, including personalized medicine and improved diagnostic tools, aimed at enhancing patient care and reducing healthcare costs.... Read More
